Flightless-I is a potential biomarker for the early detection of alcoholic liver disease
- 7 November 2020
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 183, 114323
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Alcohol Abuse and Alcoholism (RO1 AA010541)
This publication has 37 references indexed in Scilit:
- Oxidative stress and redox signaling mechanisms of alcoholic liver disease: Updated experimental and clinical evidenceJournal of Digestive Diseases, 2011
- Interleukin-22 Treatment Ameliorates Alcoholic Liver Injury in a Murine Model of Chronic-Binge Ethanol Feeding: Role of Signal Transducer and Activator of Transcription 3Hepatology, 2010
- Nucleoredoxin Negatively Regulates Toll-like Receptor 4 Signaling via Recruitment of Flightless-I to Myeloid Differentiation Primary Response Gene (88)Journal of Biological Chemistry, 2010
- Endotoxemia and gut barrier dysfunction in alcoholic liver disease†Hepatology, 2009
- Attenuation of Flightless I, an actin-remodelling protein, improves burn injury repair via modulation of transforming growth factor (TGF)-β1 and TGF-β3British Journal of Dermatology, 2009
- Alcohol metabolites and lipopolysaccharide: Roles in the development and/or progression of alcoholic liver diseaseWorld Journal of Gastroenterology, 2009
- Flightless-I regulates proinflammatory caspases by selectively modulating intracellular localization and caspase activityJournal of Cell Biology, 2008
- Flightless I: An actin-remodelling protein and an important negative regulator of wound repairThe International Journal of Biochemistry & Cell Biology, 2008
- Recombinant Hep G2 cells that express alcohol dehydrogenase and cytochrome P450 2E1 as a model of ethanol-elicited cytotoxicityThe International Journal of Biochemistry & Cell Biology, 2006
- Intracellular Signaling Pathways Involved in Acetaldehyde–Induced Collagen and Fibronectin Gene Expression in Human Hepatic Stellate CellsHepatology, 2001